Trial Outcomes & Findings for Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein (NCT NCT02236338)

NCT ID: NCT02236338

Last Updated: 2018-05-14

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

200 participants

Primary outcome timeframe

Annual follow up, up to 75 months

Results posted on

2018-05-14

Participant Flow

Participant milestones

Participant milestones
Measure
Radiofrequency Ablation
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Overall Study
STARTED
100
100
Overall Study
COMPLETED
100
100
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Radiofrequency Ablation
n=100 Participants
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
n=100 Participants
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Total
n=200 Participants
Total of all reporting groups
Age, Continuous
47 years
n=5 Participants
48.5 years
n=7 Participants
48 years
n=5 Participants
Sex: Female, Male
Female
80 Participants
n=5 Participants
77 Participants
n=7 Participants
157 Participants
n=5 Participants
Sex: Female, Male
Male
20 Participants
n=5 Participants
23 Participants
n=7 Participants
43 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Caucasian
78 Participants
n=5 Participants
70 Participants
n=7 Participants
148 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · African American
16 Participants
n=5 Participants
18 Participants
n=7 Participants
34 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
3 Participants
n=5 Participants
7 Participants
n=7 Participants
10 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Asian
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Other
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Annual follow up, up to 75 months

Population: The mean long-term followup in the EVLA group was 44 (12-64) months, and the mean long-term follow-up in the RFA group was 42 (12-75) months.

Outcome measures

Outcome measures
Measure
Radiofrequency Ablation
n=87 Participants
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
n=89 Participants
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Percentage of Participants Without Recurrent Clinical Symptoms of an Incompetent Greater Saphenous Vein After Treatment.
79.3 percentage of total participants
77.5 percentage of total participants

SECONDARY outcome

Timeframe: up to 6 weeks post intervention

Number of acute complications at one and 6 weeks post intervention

Outcome measures

Outcome measures
Measure
Radiofrequency Ablation
n=100 Participants
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
n=100 Participants
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Incidence Rate of Acute Complications
0 number of complications
0 number of complications

OTHER_PRE_SPECIFIED outcome

Timeframe: During post procedure recovery period in clinic, an expected average of 2 hours after surgery.

Measured with Visual Analog Scale (VAS), with a range of 1-10 with 10 being the most pain.

Outcome measures

Outcome measures
Measure
Radiofrequency Ablation
n=100 Participants
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
n=100 Participants
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Incidence of Post-procedure Pain
1 units on a scale
Interval 1.0 to 10.0
3 units on a scale
Interval 1.0 to 10.0

OTHER_PRE_SPECIFIED outcome

Timeframe: During post procedure recovery period in clinic, an expected average of 2 hours after surgery.

Measured with bruising scale, with a range of 1-10 with 10 being the most bruising.

Outcome measures

Outcome measures
Measure
Radiofrequency Ablation
n=100 Participants
Device: ClosureFAST radiofrequency catheter (VNUS Medical Technologies Inc, San Jose, CA). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. ClosureFAST radiofrequency catheter
Laser Ablation
n=100 Participants
Device: EVLT 980nm diode laser system (Angiodynamics, Queensbury, NY). Patients will have the intervention, ablation of the incompetent greater saphenous vein, using this device. Ablation of the Incompetent Greater Saphenous Vein: For each patient, the Greater Saphenous Vein (GSV) will be accessed just below the knee. After liberal use of anesthesia, the patient will undergo an ablation of the GSV. Half the patients will have this procedure performed using the Laser Ablation device and half will be treated using the Radiofrequency Ablation device. They will be randomly assigned to treatment. EVLT 980nm diode laser system
Incidence of Objective Post-procedure Bruising
2 units on a scale
Interval 1.0 to 9.0
3 units on a scale
Interval 1.0 to 8.0

Adverse Events

Radiofrequency Ablation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Laser Ablation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Malcolm Sydnor

Virginia Commonwealth University

Phone: (804) 828-0534

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place